title: Global Advisory Committee  on Vaccine Safety,  3–4 December 2014.
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D026683:Advisory Committees; D002986:Clinical Trials as Topic; D053059:Dengue Vaccines / Q000009:adverse effects* / Q000276:immunology; D046129:Ebola Vaccines / Q000009:adverse effects* / Q000276:immunology; D005260:Female; D006801:Humans; D007223:Infant; D033181:Information Dissemination; D020407:Internet / Q000592:standards*; D017780:Malaria Vaccines / Q000009:adverse effects* / Q000276:immunology; D008297:Male; D011159:Population Surveillance / Q000379:methods*; D011247:Pregnancy; D012308:Risk Management / Q000458:organization & administration / Q000592:standards*; D014613:Vaccines, Attenuated / Q000009:adverse effects / Q000276:immunology; D014614:Vaccines, Synthetic / Q000009:adverse effects / Q000276:immunology; D014944:World Health Organization
chemical_list: D053059:Dengue Vaccines; D046129:Ebola Vaccines; D017780:Malaria Vaccines; D014613:Vaccines, Attenuated; D014614:Vaccines, Synthetic